Clearmind Medicine Inc.
CMND · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,314 | -$784 | -$1,072 | -$885 |
| Dep. & Amort. | $13 | $12 | $12 | $12 |
| Deferred Tax | $8 | $21 | $39 | $0 |
| Stock-Based Comp. | $78 | $232 | $381 | $0 |
| Change in WC | $208 | -$70 | -$188 | $272 |
| Other Non-Cash | -$78 | -$509 | -$438 | -$476 |
| Operating Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$200 | -$13 | -$349 |
| Inv. Sales/Matur. | $113 | -$0 | $83 | $0 |
| Other Inv. Act. | $0 | -$0 | $0 | -$1 |
| Investing Cash Flow | $113 | -$200 | $69 | -$350 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$15 | -$10 | -$10 | -$10 |
| Stock Issued | $8 | -$0 | $415 | $351 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | $0 | $0 | -$17 |
| Financing Cash Flow | -$11 | -$10 | $405 | $323 |
| Forex Effect | $6 | $0 | -$1 | -$1 |
| Net Chg. in Cash | -$977 | -$1,309 | -$793 | -$1,106 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,473 | $5,781 | $6,574 | $7,680 |
| End Cash | $3,495 | $4,473 | $5,781 | $6,574 |
| Free Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |